Stock Analysis on Net

CVS Health Corp. (NYSE:CVS)

$24.99

Cash Flow Statement

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

CVS Health Corp., consolidated cash flow statement

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Net income
Depreciation and amortization
Loss on assets held for sale
Store impairments
Goodwill impairment
Stock-based compensation
(Gain) loss on sale of subsidiaries
Loss on early extinguishment of debt
Deferred income taxes
Other noncash items
Accounts receivable, net
Inventories
Other assets
Accounts payable and pharmacy claims and discounts payable
Health care costs payable and other insurance liabilities
Other liabilities
Change in operating assets and liabilities, net of effects from acquisitions
Adjustments required to reconcile net income to net cash provided by operating activities
Net cash provided by operating activities
Proceeds from sales and maturities of investments
Purchases of investments
Purchases of property and equipment
Proceeds from sale-leaseback transactions
Acquisitions, net of cash and restricted cash acquired
Proceeds from sale of subsidiaries, net of cash and restricted cash sold
Other
Net cash used in investing activities
Commercial paper borrowings (repayments), net
Proceeds from issuance of short-term loan
Repayment of short-term loan
Proceeds from issuance of long-term debt
Repayments of long-term debt
Derivative settlements
Repurchase of common stock
Dividends paid
Proceeds from exercise of stock options
Payments for taxes related to net share settlement of equity awards
Other
Net cash provided by (used in) financing activities
Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at the beginning of the period
Cash, cash equivalents and restricted cash at the end of the period

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Cash flow statement item Description The company
Net cash provided by operating activities Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. CVS Health Corp. net cash provided by operating activities decreased from 2021 to 2022 and from 2022 to 2023.
Net cash used in investing activities Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. CVS Health Corp. net cash used in investing activities increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.
Net cash provided by (used in) financing activities Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. CVS Health Corp. net cash provided by (used in) financing activities increased from 2021 to 2022 and from 2022 to 2023.